Marine Drugs (Jun 2022)

Call the Eckols: Present and Future Potential Cancer Therapies

  • Pedro Monteiro,
  • Silvia Lomartire,
  • João Cotas,
  • João C. Marques,
  • Leonel Pereira,
  • Ana M. M. Gonçalves

DOI
https://doi.org/10.3390/md20060387
Journal volume & issue
Vol. 20, no. 6
p. 387

Abstract

Read online

In recent years, an increased interest in marine macroalgae bioactive compounds has been recorded due to their benefits to human health and welfare. Several of their bioactivities have been demonstrated, such as anti-inflammatory, antioxidant, anticarcinogenic, antibacterial and antiviral behavior. However, there still lacks a clear definition regarding how these compounds exert their bioactive properties. Of all the bioactive compounds derived from marine macroalgae, attention has been focused on phenolic compounds, specifically in phlorotannins, due to their potential for biomedical applications. Phlorotannins are a diverse and wide group of phenolic compounds, with several structural variations based on the monomer phloroglucinol. Among the diverse phlorotannin structures, the eckol-family of phlorotannins demonstrates remarkable bioactivity, notably their anti-tumoral properties. However, the molecular mechanisms by which this activity is achieved remain elusive and sparse. This review focuses on the described molecular mechanisms of anti-tumoral effects by the eckol family of compounds and the future prospects of these molecules for potential application in oncology therapies.

Keywords